NYSEARCA:XPH - SPDR S&P Pharmaceuticals ETF Stock Price, News & Analysis

$35.92
+0.47 (+1.33 %)
(As of 08/18/2019 04:00 PM ET)
Add
Today's Range
$35.55
Now: $35.92
$36.04
50-Day Range
$35.66
MA: $38.12
$40.51
52-Week Range
$34.51
Now: $35.92
$49.97
Volume30,100 shs
Average Volume58,066 shs
Market Capitalization$188.58 million
P/E RatioN/A
Dividend Yield0.84%
BetaN/A
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Basic Details

Issuer SSgA
Fund NameSPDR S&P Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:XPH
Inception Date6/19/2006
Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson
Phone+1-617-6644738

Fund Focus

Asset ClassEquity
BenchmarkS&P Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$188.80 million
Average Daily Volume$57,712.40
Discount/Premium-0.04%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerCredit Suisse

Receive XPH News and Ratings via Email

Sign-up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)
Currency Exposure of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)
Sector Exposure of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)
Industry Exposure of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Frequently Asked Questions

What is SPDR S&P Pharmaceuticals ETF's stock symbol?

SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XPH."

How often does SPDR S&P Pharmaceuticals ETF pay dividends? What is the dividend yield for SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF declared a quarterly dividend on Monday, March 18th. Stockholders of record on Tuesday, March 19th will be paid a dividend of $0.0678 per share on Thursday, March 21st. This represents a $0.27 annualized dividend and a dividend yield of 0.76%. The ex-dividend date of this dividend is Monday, March 18th. View SPDR S&P Pharmaceuticals ETF's Dividend History.

Has SPDR S&P Pharmaceuticals ETF been receiving favorable news coverage?

News coverage about XPH stock has trended negative on Sunday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. SPDR S&P Pharmaceuticals ETF earned a news sentiment score of -2.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for SPDR S&P Pharmaceuticals ETF.

What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Micron Technology (MU), Pfizer (PFE), Achillion Pharmaceuticals (ACHN), Baidu (BIDU), CSX (CSX), GW Pharmaceuticals PLC- (GWPH), IQIYI (IQ), Bank of America (BAC), Citigroup (C) and Chipotle Mexican Grill (CMG).

Who are SPDR S&P Pharmaceuticals ETF's key executives?

SPDR S&P Pharmaceuticals ETF's management team includes the folowing people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

Who are SPDR S&P Pharmaceuticals ETF's major shareholders?

SPDR S&P Pharmaceuticals ETF's stock is owned by a number of of institutional and retail investors. Top institutional investors include Morgan Stanley (7.75%), JPMorgan Chase & Co. (6.55%), Bank of America Corp DE (2.43%), Wells Fargo & Company MN (1.46%), Hochman Cole Investment Advisors Inc. (1.34%) and Cypress Capital Management LLC (1.08%).

Which institutional investors are selling SPDR S&P Pharmaceuticals ETF stock?

XPH stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Bank of America Corp DE, Advisor Group Inc., Tower Research Capital LLC TRC , Jane Street Group LLC, Worth Venture Partners LLC, Commonwealth Equity Services LLC and Bank of Montreal Can.

Which institutional investors are buying SPDR S&P Pharmaceuticals ETF stock?

XPH stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Cypress Capital Management LLC, Citadel Advisors LLC, D. E. Shaw & Co. Inc., Royal Bank of Canada, Pacific Sun Financial Corp, Susquehanna International Group LLP and LPL Financial LLC.

How do I buy shares of SPDR S&P Pharmaceuticals ETF?

Shares of XPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SPDR S&P Pharmaceuticals ETF's stock price today?

One share of XPH stock can currently be purchased for approximately $35.92.

How big of a company is SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF has a market capitalization of $188.58 million. View Additional Information About SPDR S&P Pharmaceuticals ETF.

What is SPDR S&P Pharmaceuticals ETF's official website?

The official website for SPDR S&P Pharmaceuticals ETF is http://www.spdrs.com/.

How can I contact SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF's mailing address is State Street Financial Center One Lincoln Street, BOSTON, MA 02111, United States. The company can be reached via phone at +1-617-6644738.


MarketBeat Community Rating for SPDR S&P Pharmaceuticals ETF (NYSEARCA XPH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  67
MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Pharmaceuticals ETF and other stocks. Vote "Outperform" if you believe XPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel